CHADDS FORD, PA, May 12, 2005 -- I-trax, Inc. (Amex: DMX), a leader in integrated health and productivity management, announced today that CHD Meridian Healthcare, an I-trax company, has expanded services at its existing on-site pharmacy in Georgetown and implemented on-site pharmaceutical services at four additional Toyota sites across the United States.
CHD Meridian Healthcare has been managing an on-site pharmacy for Toyota in Georgetown, Kentucky since July, 2003. The expanded relationship broadened the services offered at the Georgetown plant as well as initiated pharmacy services at Toyota’s manufacturing locations in Alabama, Indiana and West Virginia, and at the company's North American manufacturing headquarters in Erlanger, Kentucky. The company opened these on-site pharmacies in the first quarter.
In addition to the on-site pharmacies, CHD Meridian Healthcare facilitates mail-order services for Toyota. Through this service, CHD Meridian Healthcare supplies top-quality prescriptions at discounted costs to Toyota team members who do not live near the on-site locations. Improved efficiencies brought by CHD Meridian Healthcare allow Toyota to decrease pharmacy inflation and maintain one of the best benefit programs in the industry without passing on costs to team members.
I-trax’s chairman, Frank A. Martin, stated, “Toyota is a world class employer who continues to raise the bar of excellence in providing team members and their families with quality, cost-effective healthcare services. We are proud to have this opportunity to expand our relationship with a client as prestigious as Toyota, and we remain committed to delivering at the peak performance levels that Toyota demands of us.”
Safe Harbor Statement: This news release may contain "forward-looking statements" with the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties, which could cause actual results to differ materially from those anticipated, including those risks detailed in I-trax’s filings with the Securities and Exchange Commission, and should be read in light of these risks.